Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.
Papatheodoridis GV, Dalekos GN, Idilman R, Sypsa V, Van Boemmel F, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Loglio A, Papatheodoridi M, Gatselis N, Veelken R, Lopez-Gomez M, Hansen BE, Savvidou S, Kourikou A, Vlachogiannakos J, Galanis K, Yurdaydin C, Esteban R, Janssen HLA, Berg T, Lampertico P. Papatheodoridis GV, et al. Among authors: vlachogiannakos j. JHEP Rep. 2021 Apr 20;3(3):100290. doi: 10.1016/j.jhepr.2021.100290. eCollection 2021 Jun. JHEP Rep. 2021. PMID: 34041470 Free PMC article.
A Greek survey of community prevalence and characteristics of constipation.
Papatheodoridis GV, Vlachogiannakos J, Karaitianos I, Karamanolis DG. Papatheodoridis GV, et al. Among authors: vlachogiannakos j. Eur J Gastroenterol Hepatol. 2010 Mar;22(3):354-60. doi: 10.1097/MEG.0b013e32832bfdf0. Eur J Gastroenterol Hepatol. 2010. PMID: 19474747
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.
Manolakopoulos S, Kranidioti H, Goulis J, Vlachogiannakos J, Elefsiniotis J, Kouroumalis EA, Koskinas J, Kontos G, Evangelidou E, Doumba P, Sinakos E, Vafiadou Ι, Koulentaki M, Papatheodoridis G, Akriviadis E. Manolakopoulos S, et al. Among authors: vlachogiannakos j. Ann Gastroenterol. 2015 Oct-Dec;28(4):481-6. Ann Gastroenterol. 2015. PMID: 26423714 Free PMC article.
Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease.
Bamias G, Gizis M, Delladetsima I, Laoudi E, Siakavellas SI, Koutsounas I, Kaltsa G, Vlachogiannakos J, Vafiadis-Zouboulis I, Daikos GL, Papatheodoridis GV, Ladas SD. Bamias G, et al. Among authors: vlachogiannakos j. Can J Gastroenterol Hepatol. 2016;2016:2637010. doi: 10.1155/2016/2637010. Epub 2016 Aug 9. Can J Gastroenterol Hepatol. 2016. PMID: 27595094 Free PMC article.
Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece.
Voulgaris T, Vlachogiannakos J, Ioannidou P, Papageorgiou MV, Zampeli E, Karagiannakis D, Georgiou A, Papazoglou A, Karamanolis G, Papatheodoridis GV. Voulgaris T, et al. Among authors: vlachogiannakos j. Eur J Gastroenterol Hepatol. 2017 Mar;29(3):264-270. doi: 10.1097/MEG.0000000000000788. Eur J Gastroenterol Hepatol. 2017. PMID: 27922484
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G. Kostas A, et al. Among authors: vlachogiannakos j. World J Gastroenterol. 2017 Nov 7;23(41):7387-7396. doi: 10.3748/wjg.v23.i41.7387. World J Gastroenterol. 2017. PMID: 29151692 Free PMC article.
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
Papatheodoridis GV, Rigopoulou EI, Papatheodoridi M, Zachou K, Xourafas V, Gatselis N, Hadziyannis E, Vlachogiannakos J, Manolakopoulos S, Dalekos GN. Papatheodoridis GV, et al. Among authors: vlachogiannakos j. Antivir Ther. 2018;23(8):677-685. doi: 10.3851/IMP3256. Antivir Ther. 2018. PMID: 30044765
Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
Papatheodoridis GV, Rigopoulou EI, Papatheodoridi M, Zachou K, Xourafas V, Gatselis N, Hadziyannis E, Vlachogiannakos J, Manolakopoulos S, Dalekos GN. Papatheodoridis GV, et al. Among authors: vlachogiannakos j. Antivir Ther. 2018;23(8):711. doi: 10.3851/IMP3261. Antivir Ther. 2018. PMID: 30091421 No abstract available.
107 results